Prevalence of Macrovascular Disease in Type 2 Diabetes Mellitus
NCT ID: NCT00298844
Last Updated: 2007-03-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
350 participants
OBSERVATIONAL
2006-01-31
2010-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiac Function and Microcirculation: Type 2 DIABetes and ECHOcardiographic Changes Over Time
NCT02956577
Prevalence and Determinants of Subclinical Cardiovascular Dysfunction in Adults With Type 2 Diabetes Mellitus
NCT03132129
Clinical Observation of Coronary Arterial Microcirculation Dysfunction in Diabetic Patients With Non- Obstructive Coronary Artery Disease
NCT02748980
A Study of People With Type 2 Diabetes Who Have Diseases That Affect the Heart and Blood Vessels. The Study Will Also Look at the Treatment of a Group of These People in Hospitals in Portugal
NCT03797885
Carotid Atherosclerosis and Vascular Events in People With Diabetes
NCT02929355
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
DEFINED_POPULATION
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fasting C-peptide \> 300 pmol/l.
Exclusion Criteria
* Suspected short lifespan because of malignant disease or end-stage kidney disease.
* Pregnancy or planned pregnancy during the study period.
* Body weight \> 150 kg.
* Physical or mental disability not enabling participation in the study.
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Odense University Hospital
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mikael K. Poulsen, PhD student
Role: PRINCIPAL_INVESTIGATOR
Odense University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Odense University Hospital
Odense, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Pedersen L, Nybo M, Poulsen MK, Henriksen JE, Dahl J, Rasmussen LM. Plasma calprotectin and its association with cardiovascular disease manifestations, obesity and the metabolic syndrome in type 2 diabetes mellitus patients. BMC Cardiovasc Disord. 2014 Dec 19;14:196. doi: 10.1186/1471-2261-14-196.
Poulsen MK, Dahl JS, Henriksen JE, Hey TM, Hoilund-Carlsen PF, Beck-Nielsen H, Moller JE. Left atrial volume index: relation to long-term clinical outcome in type 2 diabetes. J Am Coll Cardiol. 2013 Dec 24;62(25):2416-2421. doi: 10.1016/j.jacc.2013.08.1622. Epub 2013 Sep 24.
Poulsen MK, Nybo M, Dahl J, Hosbond S, Poulsen TS, Johansen A, Hoilund-Carlsen PF, Beck-Nielsen H, Rasmussen LM, Henriksen JE. Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus. Cardiovasc Diabetol. 2011 Aug 12;10:76. doi: 10.1186/1475-2840-10-76.
Poulsen MK, Henriksen JE, Vach W, Dahl J, Moller JE, Johansen A, Gerke O, Haghfelt T, Hoilund-Carlsen PF, Beck-Nielsen H. Identification of asymptomatic type 2 diabetes mellitus patients with a low, intermediate and high risk of ischaemic heart disease: is there an algorithm? Diabetologia. 2010 Apr;53(4):659-67. doi: 10.1007/s00125-009-1646-7. Epub 2010 Jan 14.
Poulsen MK, Henriksen JE, Dahl J, Johansen A, Gerke O, Vach W, Haghfelt T, Hoilund-Carlsen PF, Beck-Nielsen H, Moller JE. Left ventricular diastolic function in type 2 diabetes mellitus: prevalence and association with myocardial and vascular disease. Circ Cardiovasc Imaging. 2010 Jan;3(1):24-31. doi: 10.1161/CIRCIMAGING.109.855510. Epub 2009 Oct 21.
Poulsen MK, Henriksen JE, Dahl J, Johansen A, Moller JE, Gerke O, Vach W, Haghfelt T, Beck-Nielsen H, Hoilund-Carlsen PF. Myocardial ischemia, carotid, and peripheral arterial disease and their interrelationship in type 2 diabetes patients. J Nucl Cardiol. 2009 Nov-Dec;16(6):878-87. doi: 10.1007/s12350-009-9118-5. Epub 2009 Aug 14.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.